Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease

Amyloid-β (Aβ) accumulation and tauopathy are considered the pathological hallmarks of Alzheimer’s disease (AD), but attenuation in choline signaling, including decreased nicotinic acetylcholine receptors (nAChRs), is evident in the early phase of AD. Currently, there are no drugs that can suppress...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kazuyuki Takata, Hiroyuki Kimura, Daijiro Yanagisawa, Koki Harada, Kaneyasu Nishimura, Yoshihisa Kitamura, Shun Shimohama, Ikuo Tooyama
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2022-04-01
Reeks:Molecules
Onderwerpen:
neurodegenerative disease
nicotinic acetylcholine receptors
glial cells
neuroprotection
neuroinflammation
subtype
Online toegang:https://www.mdpi.com/1420-3049/27/9/2780
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items